Metagenics Appoints Patrick Sly as the New CEO
Metagenics, a leader in the health and wellness sector, has officially appointed Patrick Sly as its new CEO. This announcement marks an exciting new chapter for the company, as it aims for unprecedented growth in the professional supplement industry.
Transition of Leadership
Patrick Sly takes over the role of CEO from Pat Smallcombe, who successfully guided the company through a significant growth phase since 2023. Smallcombe will now serve as Co-Chair of the Board, ensuring a smooth handover of leadership and strategy.
Background of Patrick Sly
With extensive experience in the health and nutritional sectors, Sly has held leadership positions in reputable companies, most recently as Global President of Reckitt's Consumer Health division. Under his guidance, the division achieved industry-leading profitability and significant market share momentum. His prior role as Global President of Reckitt's Nutrition business involved a turnaround that restored competitiveness and improved margins.
Culture and Strategy at Metagenics
Sly's leadership is characterized by integrity, innovation, and collaboration, all of which align closely with Metagenics' mission. Having worked across five countries, Sly brings valuable insights that will help foster a high-performance culture within the organization.
Future Outlook for Metagenics
Mr. Sly expresses enthusiasm for leading Metagenics, especially acknowledging the significant growth potential in the professional supplements segment. He expressed admiration for the solid foundation laid by Smallcombe and is eager to leverage the company's strengths for future success.
About Metagenics
Founded in 1983, Metagenics is headquartered in Aliso Viejo, California, operating across North America, Europe, Asia, and Australia. The company provides high-quality nutritional supplements and medical foods, empowering healthcare practitioners to aid their patients in achieving wellness goals. With over 40 years of experience, Metagenics has established itself as a trusted brand and is rated as the top doctor-recommended supplement brand in the U.S.
About Gryphon Investors
Gryphon Investors, an established middle-market private investment firm, supports companies in various sectors, including healthcare and consumer services. With more than $10 billion in assets, Gryphon partners with management teams to drive growth and create long-lasting value. Their operational model integrates industry expertise to support the maturation of their portfolio companies.
Frequently Asked Questions
Who is Patrick Sly?
Patrick Sly is the newly appointed CEO of Metagenics, taking over from Pat Smallcombe, with a strong background in the health and nutrition sector.
What is Metagenics known for?
Metagenics is recognized as a leading provider of professional nutritional supplements and has been the #1 doctor-recommended brand in the U.S.
What was Pat Smallcombe's role before the transition?
Pat Smallcombe served as the President and CEO of Metagenics and has transitioned to the role of Co-Chair of the Board.
How long has Metagenics been in business?
Metagenics has been operating since 1983, making it over 40 years in the nutritional supplement market.
What does Gryphon Investors do?
Gryphon Investors is a private investment firm that focuses on growing mid-market companies across various sectors, including healthcare and consumer goods.
